These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24483602)

  • 21. Granulocyte macrophage-colony stimulating factor protects against substantia nigra dopaminergic cell loss in an environmental toxin model of Parkinson's disease.
    Mangano EN; Peters S; Litteljohn D; So R; Bethune C; Bobyn J; Clarke M; Hayley S
    Neurobiol Dis; 2011 Jul; 43(1):99-112. PubMed ID: 21377529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
    Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
    Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Coenzyme Q10 in Parkinson's disease. Symptomatic or neuroprotective effects?].
    Storch A
    Nervenarzt; 2007 Dec; 78(12):1378-82. PubMed ID: 17508194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of dichlorvos induced oxidative stress and nigrostriatal neuronal death by chronic coenzyme Q10 pretreatment.
    Binukumar BK; Gupta N; Bal A; Gill KD
    Toxicol Appl Pharmacol; 2011 Oct; 256(1):73-82. PubMed ID: 21843543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.
    Ebadi M; Govitrapong P; Sharma S; Muralikrishnan D; Shavali S; Pellett L; Schafer R; Albano C; Eken J
    Biol Signals Recept; 2001; 10(3-4):224-53. PubMed ID: 11351130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons.
    Yuan WJ; Yasuhara T; Shingo T; Muraoka K; Agari T; Kameda M; Uozumi T; Tajiri N; Morimoto T; Jing M; Baba T; Wang F; Leung H; Matsui T; Miyoshi Y; Date I
    BMC Neurosci; 2008 Aug; 9():75. PubMed ID: 18671880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.
    Yang X; Zhang Y; Xu H; Luo X; Yu J; Liu J; Chang RC
    Curr Top Med Chem; 2016; 16(8):858-66. PubMed ID: 26311425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration.
    Manning-Bog AB; McCormack AL; Purisai MG; Bolin LM; Di Monte DA
    J Neurosci; 2003 Apr; 23(8):3095-9. PubMed ID: 12716914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.
    Abdin AA; Hamouda HE
    Neuropharmacology; 2008 Dec; 55(8):1340-6. PubMed ID: 18817789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation.
    Masotta NE; Martinefski MR; Lucangioli S; Rojas AM; Tripodi VP
    Int J Pharm; 2019 Feb; 556():9-20. PubMed ID: 30529659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of Rapid Influx of Extracellular Zn
    Tamano H; Morioka H; Nishio R; Takeuchi A; Takeda A
    Mol Neurobiol; 2019 Jun; 56(6):4539-4548. PubMed ID: 30341553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coenzyme Q10 supplementation in acute ischemic stroke: Is it beneficial in short-term administration?
    Ramezani M; Sahraei Z; Simani L; Heydari K; Shahidi F
    Nutr Neurosci; 2020 Aug; 23(8):640-645. PubMed ID: 30404563
    [No Abstract]   [Full Text] [Related]  

  • 33. Water-soluble coenzyme Q10 provides better protection than lipid-soluble coenzyme Q10 in a rat model of chronic tacrolimus nephropathy.
    Cui S; Luo K; Quan Y; Lim SW; Shin YJ; Lee KE; Kim HL; Ko EJ; Kim JH; Chung SJ; Bae SK; Chung BH; Yang CW
    Korean J Intern Med; 2021 Jul; 36(4):949-961. PubMed ID: 33430574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
    Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-lipoic acid and coenzyme Q10 combination ameliorates experimental diabetic neuropathy by modulating oxidative stress and apoptosis.
    Sadeghiyan Galeshkalami N; Abdollahi M; Najafi R; Baeeri M; Jamshidzade A; Falak R; Davoodzadeh Gholami M; Hassanzadeh G; Mokhtari T; Hassani S; Rahimifard M; Hosseini A
    Life Sci; 2019 Jan; 216():101-110. PubMed ID: 30393023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of Oxidative Damage by Coenzyme Q
    Gupta BK; Kumar S; Kaur H; Ali J; Baboota S
    Rejuvenation Res; 2018 Jun; 21(3):232-248. PubMed ID: 28844183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease.
    Shults CW; Haas RH; Beal MF
    Biofactors; 1999; 9(2-4):267-72. PubMed ID: 10416040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative bioavailability of two forms of a novel water-soluble coenzyme Q10.
    Zmitek J; Smidovnik A; Fir M; Prosek M; Zmitek K; Walczak J; Pravst I
    Ann Nutr Metab; 2008; 52(4):281-7. PubMed ID: 18645245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An alternative medical approach for the neuroprotective therapy to slow the progression of Parkinson's disease].
    Muroyama A
    Yakugaku Zasshi; 2013; 133(8):849-56. PubMed ID: 23903224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?
    Ossowska K; Wardas J; Smiałowska M; Kuter K; Lenda T; Wierońska JM; Zieba B; Nowak P; Dabrowska J; Bortel A; Kwieciński A; Wolfarth S
    Eur J Neurosci; 2005 Sep; 22(6):1294-304. PubMed ID: 16190885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.